Profile
PRPO DHR-PB TMO DHR IDXX A
Company Name Precipio, Inc. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $35.15M $916.76B $203.95B $153.12B $49.28B $36.74B
Employees 0.05K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO Ilan Danieli Rainer M. Blair Marc N. Casper Rainer Blair Jonathan J. Mazelsky Padraig McDonnell
Ratings
PRPO DHR-PB TMO DHR IDXX A
Quant Rating Score 1 5 3 3 3 3
Quant Rating Strong Sell Strong Buy Neutral Neutral Neutral Neutral
Trading
PRPO DHR-PB TMO DHR IDXX A
Last Close $21.03 $1261.26 $567.16 $220.44 $669 $144.52
High 52 $21.92 $1261.26 $606.74 $250.59 $722.94 $152.6
Low 52 $4.35 $1261.26 $390.2 $174.64 $361.04 $99.29
Price vs. 52 Week High -4.06 % 0 % -6.52 % -12.03 % -7.46 % -5.29 %
Price vs. 52 Week Low 383.45 % 0 % 45.35 % 26.23 % 85.3 % 45.55 %
Total Return
PRPO DHR-PB TMO DHR IDXX A
1 Month Return 21.91 % 0 % 5.24 % 5.44 % 5.29 % 1.83 %
3 Month Return 45.03 % 0 % 16.29 % 5.47 % 4.88 % 22.32 %
6 Month Return 166.88 % 0 % 37.64 % 12.41 % 29.13 % 27.03 %
9 Month Return 189.67 % 0 % 8.42 % 7.78 % 48.98 % 6.89 %
YTD Return 279.62 % 0 % 9.02 % -3.97 % 61.81 % 7.58 %
1 Year Return 242.51 % 0 % 11.4 % -4.51 % 60.69 % 14.98 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
PRPO DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.58 % 0.32 % 0.59 % - 0.77 %
Dividend Paid and Capex Coverage Ration (TTM) 3 % 3.15 % 3.62 % 3.15 % 9.48 % 2.26 %
Dividend Per Share (TTM) - 1.28 % 1.72 % 1.28 % - 1 %
Payout Ratio (TTM) - 24.29 % 9.47 % 24.29 % - 21.64 %
Profitability
PRPO DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 47.48 % 60.93 % 39.46 % 60.93 % 61.8 % 52.43 %
Return on Assets TTM -5.93 % 4.33 % 6.09 % 4.33 % 31.62 % 10.24 %
Return on Equity TTM -10.07 % 6.99 % 13.14 % 6.99 % 69.78 % 20.62 %
Return on Capital Employed TTM -12.46 % 6.7 % 8.41 % 6.7 % 61.76 % 14.25 %
Net Income Per EBT TTM 100 % 85.38 % 92.39 % 85.38 % 80.01 % 90.8 %
EBT Per Ebit TTM 60.29 % 82.4 % 90.83 % 82.4 % 97.36 % 97.03 %
EBIT Per Revenue TTM -9.66 % 20.91 % 17.96 % 20.91 % 31.6 % 21.29 %
Cash Flow To Debt Ratio TTM 25.21 % 34.84 % 19.85 % 34.84 % 139.39 % 46.48 %
Receivables Turnover TTM 11 6.28 5.01 6.28 7.79 4.67
Payables Turnover TTM 9.93 5.2 - 5.2 14.89 5.8
Inventory Turnover TTM 14.35 3.86 4.97 3.86 4.35 3.22
Fixed Asset Turnover TTM 505.16 % 444.19 % 421.73 % 444.19 % 575.84 % 343.45 %
Asset Turnover TTM 101.76 % 29.44 % 40.38 % 29.44 % 128.44 % 54.59 %
Operating Cash Flow Per Share TTM 0.54 9.07 20.79 9.07 14.75 5.51
Free Cash Flow Per Share TTM 0.36 7.44 16.74 7.44 13.2 4.07
Cash Per Share TTM 140.76 % 652.48 % 2687.5 % 652.48 % 224.82 % 632.16 %
Operating Cash Flow Sales Ratio TTM 4.11 % 26.12 % 17.55 % 26.12 % 27.46 % 22.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 66.63 % 81.98 % 80.49 % 81.98 % 89.45 % 73.89 %
Cash Flow Coverage Ratios TTM 25.21 % 34.84 % 19.85 % 34.84 % 139.39 % 46.48 %
Price To Free Cash Flows Ratio TTM 59.67 29.56 32.41 29.11 46.62 31.89
Price To Operating Cash Flows Ratio TTM 37.16 24.25 26.11 23.88 41.83 23.52
Price Cash Flow Ratio TTM 37.16 24.25 26.11 23.88 41.83 23.52
Income Statement (TTM)
PRPO DHR-PB TMO DHR IDXX A
Revenue $0.02B $24.57B $44.56B $24.57B $4.3B $6.95B
Gross Profit $0.01B $14.97B $16.78B $14.97B $2.66B $3.64B
Gross Profit Ratio 47.35% 60.93% 37.66% 60.93% 61.8% 52.43%
EBITDA $-0B $6.95B $10.89B $6.95B $1.47B $1.84B
Net Income $-0B $3.61B $6.74B $3.61B $1.06B $1.3B
EPS Diluted -2.93 5.04 17.74 5.04 13.08 4.57
Balance Sheet (MRQ)
PRPO DHR-PB TMO DHR IDXX A
Long Term Debt $0B $18.42B $35.85B $18.42B $0.37B $3.05B
Total Liabilities $0B $30.93B $56.81B $30.93B $1.75B $5.99B
Total Equity $0.01B $52.54B $53.54B $52.54B $1.61B $6.74B
Total Investments $0B $0B $0.25B $0B $0B $0.13B
Total Debt $0B $18.42B $39.39B $18.42B $0.85B $3.35B
Total Assets $0.02B $83.46B $110.34B $83.46B $3.35B $12.73B
Cash Flow Statement (TTM)
PRPO DHR-PB TMO DHR IDXX A
Net Income $-0B $3.61B $6.72B $3.61B $1.06B $0.43B
Inventory $-0B $-0.06B $0B $-0.06B $0B $0.05B
Dividends Paid $0B $-0.88B $-0.64B $-0.88B $0B $-0.28B
Operating Cash Flow $0B $6.42B $7.82B $6.42B $1.18B $1.56B
Capital Expenditure $-0B $-1.16B $-1.53B $-1.16B $-0.12B $-0.41B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 125.77
ACRS Aclaris Therapeutics, Inc. 3.235
ADVB Advanced Biomed Inc. Common Stock 0.25
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 5.62
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 11.72
BIAF bioAffinity Technologies, Inc. 1.08
BIAFW bioAffinity Technologies, Inc. 0.2258
BIOC Biocept, Inc. 0.4349
BLLN BillionToOne, Inc. 92.3952
BNGO Bionano Genomics, Inc. 1.11
BNGOW BioNano Genomics, Inc. WT EXP 082123 0.0036
BNR Burning Rock Biotech Limited 29.3
CDNA CareDx, Inc 19.83
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 1.68
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 161.35
ETFs With Exposure to PRPO
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 338.105
VXF Vanguard Extended Market Index Fund 0.00045 216.835
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 113.17
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 113.15
DFAU Dimensional US Core Equity Market ETF 0 47.4799
VTSAX Vanguard Total Stock Market Index Fund 0 163.59
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00045 162.32
VITSX Vanguard Total Stock Market Index Fund 0 163.62
DFSU Dimensional US Sustainability Core 1 ETF 0.00112491 43.58
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00045 162.33
VEMPX Vanguard Extended Market Index InstlPlus 0.00045 400.57
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 306.93
Unlock